{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:6041",
      "entity_text" : "duration",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00460",
      "entity_text" : "neuraminidase inhibitors",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Treatment with neuraminidase inhibitors has been shown to reduce illness duration and severe outcomes of influenza based on evidence from randomized controlled trials, meta-analyses of randomized controlled trials, and observational studies.",
  "reading_complete" : "2020-08-09T07:13:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-09T07:10:44Z",
  "trigger" : "reduce",
  "evidence" : [ "neuraminidase inhibitors has been shown to reduce illness duration" ],
  "pmc_id" : "5815487",
  "score" : 0
}